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Introduction
Carotid atherosclerosis plays a large role in the etiology of stroke and cardiovascular disease (CVD). B-mode carotid ultrasound has been widely used to detect subclinical carotid atherosclerosis by quantifying carotid intima-media thickness (cIMT) and carotid plaque (CP). Both cIMT and CP have been proposed surrogate imaging biomarkers of subclinical atherosclerosis [1, 2] until recently, when it became increasingly clear that cIMT and CP may be genetically and biologically distinct atherosclerotic phenotypes with evidence of heterogeneous etiology [3, 4] . In addition, carotid atherosclerotic plaque burden, defined as the two-dimensional total plaque area (TPA) or three-dimensional total plaque volume, may be a powerful non-invasive imaging tool for vascular risk estimation, and stronger predictor for future ischemic stroke (IS) than cIMT [5] [6] [7] [8] .
cIMT and CP have been associated with prevalent and incident atherosclerotic disease with variable effects [9] [10] [11] . Whether cIMT and CP are distinct phenotypes or represent a single trait at a different stage of atherosclerotic development is unclear. Recent studies have suggested that increased cIMT more likely represents adaptive changes to increased shear stress with aging and less likely atherosclerotic changes [12] . The biological mechanism by which increased arterial wall thickening initiates focal plaque formation is poorly understood. Therefore, a greater understanding of adaptive changes in the arterial wall with aging and of how these changes relate to the development of atherosclerosis in various populations is needed.
In the current study, we sought to examine the cross-sectional and prospective relationships between cIMT and carotid plaque phenotypes in a multi-ethnic population of northern Manhattan. We hypothesized that increased cIMT was not related to presence of carotid plaque and to development of new carotid plaque over time.
Material and Methods

Study Participants
Subjects were participants in the Northern Manhattan Study (NOMAS), an ongoing, prospective, population-based study of stroke incidence and vascular risk factors, and were concurrently enrolled in the Oral Infections and Vascular Disease Epidemiology Study (INVEST). The details of the NOMAS and INVEST designs, methods and populations have been described previously [13, 14] .
Eligible subjects were those who a) had never been diagnosed with ischemic stroke; b) were >40 years old; and c) resided in Northern Manhattan for ≥3 months, in a household with a telephone. Subjects were identified by random-digit dialing and interviews were conducted by trained bilingual research assistants. Subjects were recruited from the telephone sample (telephone response rate was 91%) to have an in-person baseline interview and assessment. The enrollment response rate was 75%, the overall participation rate was 69%, and a total of 3,298 subjects were enrolled with an average annual contact rate of 95%. Of the 3,298 subjects, ultrasound measurements of cIMT and CP were performed for 1,788, and of those, 768 had multiple ultrasound measurements over time as a part of INVEST [14] . NOMAS and INVEST are approved by the Institutional Review Boards of the Columbia University Medical Center and the University of Miami. All subjects signed written consent for participation.
Baseline Evaluation
Data were collected through interviews with trained bilingual research assistants in English or Spanish. Physical and neurological examinations were conducted by study neurologists. Race-ethnicity was based upon self-identification through a series of questions modeled after the US census and conforming to standard definitions outlined by Directive 15 [15] . Standardized questions were adapted from the Behavioral Risk Factor Surveillance System by the Centers for Disease Control regarding hypertension, diabetes, smoking, and cardiac conditions [16] . Blood pressure (BP) was measured with mercury sphygmomanometers and appropriately-sized cuffs. Hypertension was defined as a BP ≥140/90 mmHg (based on the average of two measurements during one sitting), the patient's self-reported hypertension, or use of anti-hypertensive medications. Diabetes mellitus was defined by the patient's selfreported diabetes, use of insulin or oral anti-diabetic medications, or fasting glucose ≥126 mg/dl. The fasting lipid profile was measured at enrollment. Body mass index (BMI) was calculated in kg/m 2 .
Carotid Ultrasound
High-resolution B-mode ultrasound imaging (GE LogIQ 700, 9-to 13-MHz linear-array transducer) was performed by trained and certified sonographers as previously described [17] [18] [19] . Presence of plaque was defined as a focal wall thickening or protrusion in the lumen more than 50% greater than the surrounding thickness. Carotid plaque area (mm 2 ) and maximum thickness (mm) were measured with the automated computerized edge tracking software program M'Ath (M'Ath Inc, Paris, France) [20] . TPA was defined as the sum of all plaque areas measured in any of the carotid artery segments within an individual. cIMT was measured in areas without plaque. cIMT was calculated as a composite measure of the near and the far walls of the common carotid artery (CCA) IMT, bifurcation (bif) IMT, and internal carotid artery (ICA) IMT of both sides of the neck, and examined continuously as a mean of the maximum measurements of the 12 carotid sites. We also examined cIMT in the Bifurcation and ICA exclusively and cIMT in the CCA exclusively. Likewise, we examined plaque phenotypes in the Bifurcation and ICA exclusively. Figure 1 is a representation of cIMT and carotid plaque using high-resolution B-mode ultrasound.
Statistical Analysis
The cross-sectional association between cIMT and plaque presence was examined with logistic regression models, where cIMT was the independent variable and plaque presence was the dependent variable. Due to the non-normal distribution of plaque thickness and area with a large percentage of the study population having no plaque, we used quantile regression to examine plaque thickness and area as continuous outcomes. For individuals without plaque, a value of 0 was assigned for plaque thickness and area. We chose the median (50 th percentile) and 75 th percentile as our outcome variables of interest. A three model sequence was constructed: univariate (model 1); adjusted for demographics (age, sex, race-ethnicity; model 2); and adjusted for demographics and systolic blood pressure, diastolic blood pressure, antihypertensive medication use, diabetes, low-density lipoprotein (LDL) cholesterol, high density lipoprotein (HDL) cholesterol, triglycerides, statin use, and BMI (model 3). A subset of the study population had data on left ventricular mass measured using transthoracic echocardiography, and a subset had data on diastolic intraluminal CCA diameter measured using M mode ultrasound with M'Ath software. Sensitivity analyses were conducted within these subsamples adding these two variables separately to model 3.
Next, we performed segment specific analyses as secondary exploratory analyses. We examined cIMT in the Bifurcation and ICA only in relation to plaque presence, thickness, and area in these segments only. For the latter analysis the left and right sides were examined separately. We examined cIMT in the CCA only in relation to plaque presence in any location.
Next, we used logistic regression to conduct a prospective analysis of baseline cIMT as a predictor of incident plaque from baseline to follow-up carotid ultrasound. Incident plaque was new plaque found at follow up in any of the carotid segments, which was not present at baseline at the same location. We constructed the same sequence of multivariable-adjusted models, and also controlled for the time span between the baseline and follow-up ultrasound imaging in all three models. In addition, these prospective analyses were repeated in a subpopulation restricted only to individuals who did not have carotid plaque at baseline. For each analysis, we ran exploratory models to examine any potential effects of race-ethnicity by including interaction terms between baseline cIMT and race-ethnicity while controlling for all covariates included in model 3. We used logistic regression to conduct an analysis of the change in IMT from baseline to follow up as a predictor of incident plaque in the full prospective sample as well as in those without plaque at baseline, using the same series of models described above and adjusted for the time spam between the baseline and follow up measurements.
Lastly, we ran secondary models to examine the segment-specific association between IMT and incident plaque during follow up. We examined CCA IMT at baseline as well as change in CCA IMT from baseline to follow up in relation to incident plaque in any segment. In addition, we examined ICA and bifurcation IMT at baseline as well as change in ICA and bifurcation IMT in relation to incident plaque in the ICA and bifurcation only. For the latter analysis the left and right sides were examined separately. Each of these analyses were repeated in the subsample restricted to those without plaque at baseline, and the same sequence of three models was run as described above.
Results
The characteristics of the study population broken down by plaque presence are reported in Table 1 . Among the 1,787 participants (mean age of 66±9 years, 40% male, 61% Hispanics, 19% non-Hispanic black, and 17% non-Hispanic white), 57% had plaque (N=1026), and 37% had thick plaque >1.9mm (N=657 2 for right ICA and bif). Significant independent predictors of plaque presence in this population at baseline included older age, male sex, white race, hypertension, diabetes, and elevated LDL cholesterol, while significant independent predictors of cIMT were older age, male sex, diabetes, elevated LDL, and elevated BMI (data not shown). Table 2 shows the cross-sectional association between baseline measurements of cIMT and plaque phenotypes. In all three models, cIMT was positively associated with plaque presence, plaque thickness, and TPA. Adjustment for demographics and vascular risk factors only attenuated the associations slightly. The associations remained consistent in sensitivity analyses adding left ventricular mass and diastolic CCA diameter to model 3 (data not shown). In model 3, the prevalence of plaque was increased by 72% for each 0.1mm increase in cIMT. In addition, cIMT in the Bifurcation and ICA was also positively associated with plaque presence, thickness, and TPA in the Bifurcation and ICA, and cIMT in the CCA was positively associated with plaque presence, thickness, and TPA in all segments.
The mean time-span between the two carotid measurements among those who had multiple scans was 3.5 years (range: 1.9-7.3; N=768), and 43% of participants developed a new plaque during follow-up (N=334, N=161 new plaque in left bifurcation and ICA, N=160 in the right bifurcation and ICA). Of the 324 participants without plaque at baseline, 40% developed a new plaque during follow-up (N=130, N=100 new plaque in left bifurcation and ICA, N=100 in the right bifurcation and ICA). Table 3 shows the association between cIMT at baseline and incident plaque during followup. In the univariate model 1, elevated cIMT at baseline was associated with an increased risk of incident plaque during follow-up in the full subpopulation as well as in the group without plaque at baseline. However, after adjustment for demographics and vascular risk factors the association was no longer significant. Findings remained consistent in sensitivity analyses including left ventricular mass and diastolic CCA diameter in the fully adjusted model, conducted in subsamples with available data for these variables (data not shown). This lack of the relationship between cIMT and incident plaque was observed across all race-ethnic groups (no significant interactions were found). The mean longitudinal change in cIMT was 0.11±0.16 mm among all participants, and 0.09±0.15 and 0.12±0.15 mm among those with and without plaque, respectively (p=0.01). There was a marginally statistically significant trend towards a positive association between increasing IMT from baseline to follow up and incident plaque among the full prospective study sample (p=0.06) while there was no apparent relationship among those without plaque at baseline. Table 4 shows the segment-specific relationship between baseline IMT and incident plaque in the full prospective sample, and among those without plaque at baseline. CCA IMT was positively associated with developing a new plaque in any segment during follow up, but this association was attenuated and no longer significant in multivariable-adjusted models. Among all participants, the mean longitudinal change in bifurcation and ICA cIMT was 0.11±0.18 mm for the left side (0.07±0.20 and 0.11±0.18 mm among those with and without any plaque, respectively, p=0.01) and 0.11±0.18 mm for the right side (0.08±0.21 and 0.12±0.18 mm among those with and without any plaque, respectively, p=0.01). The mean longitudinal change in CCA cIMT was 0.12±0.19 mm among all participants, and 0.12±0.18 and 0.13±0.20 mm among those with and without plaque, respectively (p=0.23). Progression in CCA IMT from baseline to follow up was positively associated with the presence of incident plaque in any location in the full sample, but the association was attenuated and no longer significant in the sample restricted to those without plaque at baseline. Baseline and progression of cIMT in the left and right ICA and bifurcation did not predict incident plaque in the respective segments.
Discussion
Accumulating evidence suggests that cIMT and CP may be distinct phenotypes rather than a manifestation of the same phenotype at different stages or phases in the progression of atherosclerosis [21] [22] [23] . Though our study design did not evaluate this hypothesis directly, the results may provide some modest indirect support. We observed a positive association between cIMT and prevalent carotid plaque phenotypes in a cross-sectional analysis, but not between cIMT and incident plaque in a prospective analysis after accounting for vascular risk factors. cIMT and carotid plaque seem to be distinct manifestation of an arterial wall thickening process although they often coexist. Carotid plaque therefore may not be a simple result of progressive intima-media thickening, but rather a "de novo" event.
One particularly novel component to the current study was the examination of segmentspecific relationships between cIMT and plaque. CCA cIMT predicted plaque presence overall, consistent with the findings of other studies [7, 8, 11, 24] . ICA and bifurcation cIMT was predictive of plaque in those segments on the same side in cross-sectional analyses, but not in longitudinal analyses, indicating that cIMT may not directly progress to plaque.
Atherosclerotic plaque formation represents a dynamic process involving a complex cascade of inflammatory events [25] while carotid intima-media thickening may be related to adaptive hypertrophy of the media layer and not a true representation of an atherosclerotic lesion [26] . Increased cIMT may be represented by "fatty streaks" composed of foamy macrophages which have a non-raised appearance in the arterial lumen and have been shown to regress rather than to progress to raised lesions even in the presence of risk factors [7] . In contrast, "pathologic intimal thickening" is increased cIMT, which represents the earliest manifestation of progressive atherosclerosis [7] and is rich in proteoglycans and lipids, lacks smooth-muscle cells and collagen, and may rapidly transform into plaque through mechanisms not entirely understood. Ultrasonographic measurement of cIMT however cannot distinguish these two different intima-media thickening processes. The strong relationship between cIMT and plaque in our cross-sectional analysis was most likely a result of "pathological intimal thickening" present among those individuals with atherosclerotic plaque, sharing a common pathological mechanism, which was not completely explained by the presence of traditional vascular risk factors. In the prospective analyses however, this association attenuated after adjustment for vascular risk factors, suggesting a distinct mechanism leading to formation of incident plaque, rather than a continuum of the development of plaque from intima-media thickening. Distinct mechanisms underlying the development of plaque and cIMT has been further suggested by evidence from genetic studies which demonstrated that variants in genes encoding proteins implicated in pathways leading to formation of carotid atherosclerosis (eg oxidative stress, inflammation, and diabetes) were differentially associated with cIMT and carotid plaque [21] [22] [23] . This suggests that these two phenotypes of carotid atherosclerosis, even if correlated, could be under different biological and genetic control. Although the two processes-cIMT and plaque formation-may share some common mechanisms, their overlap is partial, and their predictive power of cerebrovascular disease (CVD) risk differs [6, [27] [28] [29] .
The relationship between cIMT and carotid plaque has been examined previously. The European Vascular Aging (EVA) Study demonstrated a significant association between increased cIMT measured in the CCA and both the presence and severity of atherosclerotic plaque [29] . In a longitudinal EVA study [30] , the odds of having CP was 2.7-fold greater in subjects with intermediate baseline cIMT values, and 3. 7-fold greater among those with the highest baseline cIMT values compared to subjects with the lowest baseline cIMT values. Interestingly, adjustments for major vascular risk factors did not modify these values. We did not confirm these observations. Although our study had similar duration of follow up (3.5 years in our study, 4 years in EVA), discrepant results most likely are related to the differences in characteristics of the study populations, definitions of risk factors, and definition of plaque. Several studies conducted in predominantly Caucasian populations reported cross-sectional associations between cIMT and plaque [31] [32] [33] . In addition, five longitudinal studies, with time spans from four to twelve years, have shown positive associations between cIMT, particularly in the CCA, with the development of carotid plaque [24, 30, [34] [35] [36] . Our findings regarding CCA cIMT in relation to incident plaque are not inconsistent with the latter studies. However, differences in study design, including longer follow up in other studies [34, 35] , categorization of cIMT [24, 30, 34] rather than a continuous examination, as well as differences in study sample characteristics and size may explain variability in findings. The other longitudinal studies did not examine lateralspecific ICA and bif cIMT in relation to incident plaque like we did.
In the present study, an association between cIMT and plaque at baseline was present in all race-ethnic groups, but a more robust association was found in Hispanics than in blacks and whites. The Atherosclerosis Risk in Communities (ARIC) Study showed no difference between whites and blacks in site-specific prevalence of carotid plaque, as well as a positive association between plaque and cIMT at baseline in both race-ethnicities [32] . Differences in carotid geometry, vascular risk factor profiles and differential predisposition to vascular remodeling and atherosclerotic development may be among possible factors explaining these race-ethnic variations [27, 37, 38] .
Our results do not provide direct evidence to confirm the hypothesis that carotid plaque may be a biologically different atherosclerosis phenotype from cIMT, though some of our findings are consistent with this hypothsis. Although carotid plaque seems to be more strongly influenced by environmental factors [39] than cIMT, we have reported that traditional vascular risk factors explain about 21% of the variance in the total carotid plaque burden [20] and only 11% of the variance in cIMT [40] . This suggests that other unaccounted factors, both environment and genetic, play an important role in the determination of these phenotypes. The Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium showed different genetic loci associated with cIMT and carotid plaque [41] . Similarly, we observe no overlap in genetic variants associated with cIMT and CP in our family study [21, 22, [42] [43] [44] .
Strengths of the current study include its multi-ethnic population-based design, a systematic collection of vascular risk factors, inclusion of both cross-sectional and prospective analyses, and the use of multiple plaque phenotypes for comparisons. However, our study has several limitations. Our population is an older cohort with high burden of risk factors and great proportion of carotid plaque at baseline. Our conclusions may not be generalizable to younger and healthier populations. Also, the population sample available for our crosssectional analysis was much larger than that used in our prospective analysis, limiting the power of the longitudinal analysis. Further research with multiple follow-up ultrasound measurements and starting earlier in life is needed to fully elucidate the complex temporal relationship between intima-media thickening and plaque formation, and to determine how these atherosclerotic phenotypes interact to affect stroke risk in various populations. The left side is a representation of a left bifurcation carotid artery plaque measurement, and the right side is a representation of right common carotid artery cIMT measurement using high-resolution B-model ultrasound. Table 3 Prospective association between IMT at baseline and plaque presence at follow up 
